- Home
- PLSE
as 12-24-2024 1:41pm EST
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | HAYWARD |
| Market Cap: | 1.1B | IPO Year: | 2016 |
| Target Price: | N/A | AVG Volume (30 days): | 181.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.83 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.60 - $22.69 | Next Earning Date: | 10-30-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Pulse Biosciences Inc (DE) (PLSE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| DUGGAN ROBERT W | PLSE | Director10% Owner | Dec 13 '24 | Buy | $17.18 | 55,256 | $949,298.08 | 42,328,717 | |
| DUGGAN ROBERT W | PLSE | Director10% Owner | Dec 11 '24 | Buy | $17.08 | 56,054 | $972,343.96 | 42,328,717 | |
| Barrett Burke Thomas | PLSE | N/A | Dec 11 '24 | Sell | $17.42 | 50,000 | $871,000.00 | 63,172 |
Latest Pulse Biosciences Inc (DE) News
PLSE Breaking Stock News: Dive into PLSE Ticker-Specific Updates for Smart Investing
Business Wire
a day ago
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
Business Wire
5 days ago
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
Argus Research
6 days ago
Daily – Vickers Top Buyers & Sellers for 12/18/2024
Business Wire
7 days ago
Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery
Simply Wall St.
8 days ago
Robert Duggan Spends US$972k On Pulse Biosciences Stock
Simply Wall St.
12 days ago
Top Key Executive Robert Duggan, Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder sees value of holdings go down 13% after recent drop
MT Newswires
a month ago
Pulse Biosciences Stock Rises; Co-Chairman Duggan May Buy Shares
Simply Wall St.
a month ago
Pulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth Plans
Compare PLSE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PLSE Pulse Biosciences Inc (DE) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.